The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 2, 1997, Pages 210-216

  Lin, Chien Huang ^a   Ko, Feng Nien ^a   Ishii, Hisahi ^b   Ishikawa, Tsutomu ^b   Chen, Ih Sheng ^c   Teng, Che Ming ^a   Kuo, Han Pin ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHIBA UNIVERSITY   (Japan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Antigen challenge; Bronchial hyperreactivity; Bronchoconstriction; Guinea pigs; Microvascular leakage; PAF receptor antagonist

Indexed keywords

1,2,3,4 TETRAHYDRO 2 (3,4 DIMETHOXYPHENYL) 6 ISOPROPOXY 7 METHOXY 1 (N METHYLFORMAMIDO)NAPHTHALENE; 2 (3,4 DIMETHOXYPHENYL) 6 ISOPROPOXY 7 METHOXY 1 (N METHYLFORMAMIDO) 1,2,3,4 TETRAHYDRONAPHTHALENE; ANTIGEN; HISTAMINE; METHACHOLINE; OVALBUMIN; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL MODEL; ARTICLE; BRONCHOSPASM; BRONCHUS; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; EXTRAVASATION; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; NONHUMAN; TRACHEA;

AIRWAY RESISTANCE; ANIMALS; ANTIGENS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; CAPILLARY PERMEABILITY; GUINEA PIGS; HISTAMINE; MALE; METHACHOLINE CHLORIDE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY HYPERSENSITIVITY; SUBSTANCE P; TETRAHYDRONAPHTHALENES;

EID: 0031021580     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004934     Document Type: Article

References (29)

1. Anderson GP, Fennesy MR (1988) Lipoxygenase metabolites mediate increased airway responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig. Agent Actions 24:8-19
2. Barnes PJ, Chung KF (1987) PAF closely mimics pathology of asthma. Trends Pharmacol Sci 8:285-287
3. Braquet P, Touqui L, Shen TY, Vargaftig BB (1987) Perspectives in platelet activating factor research. Pharmacol Rev 39:97-145
4. Chung KF (1986) Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41:657-662
5. Coyle AJ, Urwin SC, Page CP, Touvey C, Villain B, Braquet P (1988) The effects of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyperreactivity and eosinophil accumulation. Eur J Pharmacol 148:51-58
6. Danko G, Sherwood JE, Grissom B, Kreutner W, Chapman RW (1988) Effect of the PAF antagonist, CV-3988 and L-652,731 on the pulmonary and haematological responses to guinea-pig anaphylaxis. Pharmacol Res Commun 20:785-798
7. Desquand S, Lefort J, Dumarey C, Vargaftig BB (1991) Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. Br J Pharmacol 102:687-695
8. Dixon EJA, Wilsoncroft P, Robertson DN, Page CP (1989) The effects of PAF antagonists on bronchial hyperresponsiveness induced by PAF, propranolol or indomethacin. Br J Pharmacol 97:717-722
9. Evans TW, Chung KF, Rogers DF, Barnes PJ (1987) Effect of platelet activating factor on airway vascular permeability:possible mechanisms. J Appl Physiol 63:479-484
10. Evans TW, Dent G, Rogers DF, Aursudkij B, Chung KF Barnes PJ (1988) Effects of a PAF antagonist, WEB 2086 on airway microvascular leakage in the guinea-pig and platelet aggregation in man. Br J Pharmacol 94:164-168
11. Fitzgerald MF (1993) Small animal models of airway hyperresponsiveness. In: Page CP, Gardiner PJ (eds) Airway hyperresponsiveness: is it really important for asthma? Blackwell, Oxford, pp 129-150
12. Havill A, Van Valen RG, Handley DA (1990) Prevention of non-specific airway hyper-reactivity after allergen challenge in guinea pigs by the PAF receptor antagonist SDZ 64-412. Br J Pharmacol 99:396-400
13. Ishii H, Chen IS, Ishikawa T (1983) Effective total synthesis of fagaronine:Anti-leukaemic phenolic benzo[c]phenanthridine alkaloids. Chem Pharm Bull 31:2963-2966
14. Ishii H, Chen IS, Ishikawa T (1987) Studies on the chemical constituents of Rutaceous plants. Part 62, Efficient synthesis of fagaronine, a phenolic benzo[c]phenanthridine alkaloid with antileukaemic activity. J Chem Soc Perkin Trans 1:671-676
15. Kato, M, Tokuyama K, Morikawa A, Kuroume T, Barnes P (1993) Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs. Eur J Pharmacol 232:7-12
16. Ko FN, Yu SM, Chen IS, Ishii H, Chang YL, Huang TF, Teng CM (1993) CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies. Biochim Biophys Acta 1175:225-231
17. Lellouch-Tubiana A, Lefort J, Simon MT, Pfister A, Vargaftig BB (1988) Eosinophil recruitment into guinea-pig lungs after PAF-acether and allergen administration. Am Rev Respir Dis 137:948-954
18. Mazzoni L, Morley J, Page CP, Sanjar S (1985) Induction of airway hyperreactivity by platelet activating factor in the guinea-pig. J Physiol 365:107-114
19. Morooka S, Uchida M, Imanishi N (1992) Platelet-activating factor (PAF) plays an important role in the immediate astmatic response in guinea-pig by augmenting the response to histamine. Br J Pharmacol 105:756-762
20. Pretolani M, Lefort J, Malanchere E, Vargaftig BB (1987) Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Eur J Pharmacol 140:311-321
21. Pretolani M, Lefort J, Vargaftig BB (1988) Active sensitization induces lung hyperresponsiveness in the guinea-pigs: pharmacological modulation and triggering role of the booster injection. Am Rev Respir Dis 138:1572-1578
22. Pretolani M, Lefort J, Vargaftig BB (1989) Limited interference of specific PAF-acether antagonists with hyperresponsiveness to PAF-acether itself of lungs from actively sensitized guinea-pigs. Br J Pharmacol 97:433-442
23. Sanjar S, Smith D, Schaeublin E, KRistersson A, Chapoman I, Mazzoni L, Morley J (1989) The effect of prophylactic anti-asthma drugs on PAF-induced airway hyperrreactivity. Jpn J Pharmacol 51:151-160
24. Sanjar S, Aoki S, Boubekeur K, Chapman ID, Smith D, Kings MA, Morley J (1990) Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs. Br J Pharmacol 99:267-272
25. Seeds EA, Coyle AJ, Page CP (1991) The effect of the selective PAF antagonist WEB 2170 on PAF and antigen-induced bronchial hyperresponsiveness and eosinophil infiltration. J Lipid Mediators 4:111-121
26. Teng CM, Lin CH, Kuo HP, Ko FN, Ishii H, Ishikawa T, Chen IS (1995) Effects of CIS-19, a novel PAF receptor antagonist, on PAF-induced eosinophil recruitment and enhancement of superoxide anion generation in guinea-pigs. Naunyn-Schmiedeberg's Arch Pharmacol 351:529-534
27. Tokuyama K, Lotvall JO, Barnes PJ, Chung KF (1991) Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor. J Appl Physiol 71:1729-1734
28. Underwood SL, Lewis SA, Raeburn D (1992) RP 59227, a novel PAF receptor antagonist: effects on guinea-pig models of airway hyperreactivity. Eur J Pharmacol 210:97-102
29. Vargaftig BB, Lefort J, Chignard M, Benveniste J (1980) Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 65:185-192